| Catalog Number | KB-1757 |
|---|---|
| Antibody Name | Ozoralizumab |
| Isotype | Nanobody |
| FC Muations | N/A |
| Target | TNFaxHSA |
| Species Reactivity | Human |
| Host Cell Line | EXPI CHO |
| Purification Method | Affinity purified |
| Concentration | >2 mg/mL |
| Formulation | 50 mM sodium citrate,150mM NaCl,pH5.5 |
| Purity | >95% by SDS-PAGE and SEC-HPLC |
| Validation | FACS|Reporter cell blocking|KD |
| Endotoxin Level | <0.2 EU/mg as determined by the LAL method |
| Sterility | 0.2μm filtered |
| Storage | It is recommended that the protein should be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles. |
| Stability | Stable for twelve months from date of receipt when stored at -20°C to -80°C; Stored at 2-8°C for one month without detectable loss of activity. |
